Global Oral Simeglutide Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR022404024

Publication Date:

February 26, 2024

Pages:

108

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Oral Simeglutide market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Simeglutide was originally introduced to the market as a drug for the treatment of type 2 diabetes, but some studies have shown that it is also effective for weight loss. Oral Simeglutide is specifically developed for oral use. The bottom three companies on the list are all in development.
This report studies the global Oral Simeglutide production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Simeglutide, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Simeglutide that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Simeglutide total production and demand, 2019-2030, (K Units)
Global Oral Simeglutide total production value, 2019-2030, (USD Million)
Global Oral Simeglutide production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oral Simeglutide consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Oral Simeglutide domestic production, consumption, key domestic manufacturers and share
Global Oral Simeglutide production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Oral Simeglutide production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oral Simeglutide production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Oral Simeglutide market based on the following parameters 鈥� company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk A/S, Aurisco, Shanghai Benemae Pharmaceutical, Hangzhou Jiuyuan Genetic Engineering Co., Ltd., Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. and Livzon Pharmaceutical Group Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Simeglutide market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Oral Simeglutide 麻豆原创, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Oral Simeglutide 麻豆原创, Segmentation by Type
Tablets
Compulse
Global Oral Simeglutide 麻豆原创, Segmentation by Application
Online
Offline
Companies Profiled:
Novo Nordisk A/S
Aurisco
Shanghai Benemae Pharmaceutical
Hangzhou Jiuyuan Genetic Engineering Co., Ltd.
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Group Inc.
Key Questions Answered
1. How big is the global Oral Simeglutide market?
2. What is the demand of the global Oral Simeglutide market?
3. What is the year over year growth of the global Oral Simeglutide market?
4. What is the production and production value of the global Oral Simeglutide market?
5. Who are the key producers in the global Oral Simeglutide market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 Oral Simeglutide Introduction
1.2 World Oral Simeglutide Supply & Forecast
1.2.1 World Oral Simeglutide Production Value (2019 & 2023 & 2030)
1.2.2 World Oral Simeglutide Production (2019-2030)
1.2.3 World Oral Simeglutide Pricing Trends (2019-2030)
1.3 World Oral Simeglutide Production by Region (Based on Production Site)
1.3.1 World Oral Simeglutide Production Value by Region (2019-2030)
1.3.2 World Oral Simeglutide Production by Region (2019-2030)
1.3.3 World Oral Simeglutide Average Price by Region (2019-2030)
1.3.4 North America Oral Simeglutide Production (2019-2030)
1.3.5 Europe Oral Simeglutide Production (2019-2030)
1.3.6 China Oral Simeglutide Production (2019-2030)
1.3.7 Japan Oral Simeglutide Production (2019-2030)
1.4 麻豆原创 Drivers, Restraints and Trends
1.4.1 Oral Simeglutide 麻豆原创 Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Simeglutide Major 麻豆原创 Trends
2 Demand Summary
2.1 World Oral Simeglutide Demand (2019-2030)
2.2 World Oral Simeglutide Consumption by Region
2.2.1 World Oral Simeglutide Consumption by Region (2019-2024)
2.2.2 World Oral Simeglutide Consumption Forecast by Region (2025-2030)
2.3 United States Oral Simeglutide Consumption (2019-2030)
2.4 China Oral Simeglutide Consumption (2019-2030)
2.5 Europe Oral Simeglutide Consumption (2019-2030)
2.6 Japan Oral Simeglutide Consumption (2019-2030)
2.7 South Korea Oral Simeglutide Consumption (2019-2030)
2.8 ASEAN Oral Simeglutide Consumption (2019-2030)
2.9 India Oral Simeglutide Consumption (2019-2030)
3 World Oral Simeglutide Manufacturers Competitive Analysis
3.1 World Oral Simeglutide Production Value by Manufacturer (2019-2024)
3.2 World Oral Simeglutide Production by Manufacturer (2019-2024)
3.3 World Oral Simeglutide Average Price by Manufacturer (2019-2024)
3.4 Oral Simeglutide Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Simeglutide Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Simeglutide in 2023
3.5.3 Global Concentration Ratios (CR8) for Oral Simeglutide in 2023
3.6 Oral Simeglutide 麻豆原创: Overall Company Footprint Analysis
3.6.1 Oral Simeglutide 麻豆原创: Region Footprint
3.6.2 Oral Simeglutide 麻豆原创: Company Product Type Footprint
3.6.3 Oral Simeglutide 麻豆原创: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of 麻豆原创 Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Oral Simeglutide Production Value Comparison
4.1.1 United States VS China: Oral Simeglutide Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Oral Simeglutide Production Value 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Oral Simeglutide Production Comparison
4.2.1 United States VS China: Oral Simeglutide Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Oral Simeglutide Production 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Oral Simeglutide Consumption Comparison
4.3.1 United States VS China: Oral Simeglutide Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Oral Simeglutide Consumption 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Oral Simeglutide Manufacturers and 麻豆原创 Share, 2019-2024
4.4.1 United States Based Oral Simeglutide Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Simeglutide Production Value (2019-2024)
4.4.3 United States Based Manufacturers Oral Simeglutide Production (2019-2024)
4.5 China Based Oral Simeglutide Manufacturers and 麻豆原创 Share
4.5.1 China Based Oral Simeglutide Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Simeglutide Production Value (2019-2024)
4.5.3 China Based Manufacturers Oral Simeglutide Production (2019-2024)
4.6 Rest of World Based Oral Simeglutide Manufacturers and 麻豆原创 Share, 2019-2024
4.6.1 Rest of World Based Oral Simeglutide Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Simeglutide Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Oral Simeglutide Production (2019-2024)
5 麻豆原创 Analysis by Type
5.1 World Oral Simeglutide 麻豆原创 Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Tablets
5.2.2 Compulse
5.3 麻豆原创 Segment by Type
5.3.1 World Oral Simeglutide Production by Type (2019-2030)
5.3.2 World Oral Simeglutide Production Value by Type (2019-2030)
5.3.3 World Oral Simeglutide Average Price by Type (2019-2030)
6 麻豆原创 Analysis by Application
6.1 World Oral Simeglutide 麻豆原创 Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Online
6.2.2 Offline
6.3 麻豆原创 Segment by Application
6.3.1 World Oral Simeglutide Production by Application (2019-2030)
6.3.2 World Oral Simeglutide Production Value by Application (2019-2030)
6.3.3 World Oral Simeglutide Average Price by Application (2019-2030)
7 Company Profiles
7.1 Novo Nordisk A/S
7.1.1 Novo Nordisk A/S Details
7.1.2 Novo Nordisk A/S Major Business
7.1.3 Novo Nordisk A/S Oral Simeglutide Product and Services
7.1.4 Novo Nordisk A/S Oral Simeglutide Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.1.5 Novo Nordisk A/S Recent Developments/Updates
7.1.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.2 Aurisco
7.2.1 Aurisco Details
7.2.2 Aurisco Major Business
7.2.3 Aurisco Oral Simeglutide Product and Services
7.2.4 Aurisco Oral Simeglutide Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.2.5 Aurisco Recent Developments/Updates
7.2.6 Aurisco Competitive Strengths & Weaknesses
7.3 Shanghai Benemae Pharmaceutical
7.3.1 Shanghai Benemae Pharmaceutical Details
7.3.2 Shanghai Benemae Pharmaceutical Major Business
7.3.3 Shanghai Benemae Pharmaceutical Oral Simeglutide Product and Services
7.3.4 Shanghai Benemae Pharmaceutical Oral Simeglutide Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.3.5 Shanghai Benemae Pharmaceutical Recent Developments/Updates
7.3.6 Shanghai Benemae Pharmaceutical Competitive Strengths & Weaknesses
7.4 Hangzhou Jiuyuan Genetic Engineering Co., Ltd.
7.4.1 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Details
7.4.2 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Major Business
7.4.3 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Oral Simeglutide Product and Services
7.4.4 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Oral Simeglutide Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.4.5 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Recent Developments/Updates
7.4.6 Hangzhou Jiuyuan Genetic Engineering Co., Ltd. Competitive Strengths & Weaknesses
7.5 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
7.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Details
7.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Major Business
7.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Oral Simeglutide Product and Services
7.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Oral Simeglutide Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5.6 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.6 Livzon Pharmaceutical Group Inc.
7.6.1 Livzon Pharmaceutical Group Inc. Details
7.6.2 Livzon Pharmaceutical Group Inc. Major Business
7.6.3 Livzon Pharmaceutical Group Inc. Oral Simeglutide Product and Services
7.6.4 Livzon Pharmaceutical Group Inc. Oral Simeglutide Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.6.5 Livzon Pharmaceutical Group Inc. Recent Developments/Updates
7.6.6 Livzon Pharmaceutical Group Inc. Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Oral Simeglutide Industry Chain
8.2 Oral Simeglutide Upstream Analysis
8.2.1 Oral Simeglutide Core Raw Materials
8.2.2 Main Manufacturers of Oral Simeglutide Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oral Simeglutide Production Mode
8.6 Oral Simeglutide Procurement Model
8.7 Oral Simeglutide Industry Sales Model and Sales Channels
8.7.1 Oral Simeglutide Sales Model
8.7.2 Oral Simeglutide Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Novo Nordisk A/S
Aurisco
Shanghai Benemae Pharmaceutical
Hangzhou Jiuyuan Genetic Engineering Co., Ltd.
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Group Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.